CONTINUOUS RENAL REPLACEMENT THERAPY: OUR EXPERIENCE IN INTENSIVE CARE UNIT

• DOI: 10.1081/jdi-100103497
• Publication Date: 2002-07-26T16:41:17Z
• Authors: G. Splendiani; V. Mazzarella; Valentina Mazzarella; S. Cipriani; D. Zazzaro; C. U. Casciani
• Keywords: Renal replacement therapy

Continuous Renal Replacement Therapy (CRRT) indication is still discussed. We report our experience on 98 patients affected with Multiple Organ System Failure (MOSF) and renal failure (acute or chronic) requiring dialysis timely treated by CRRT. Mortality after 5 days of ICU permanence was 60.2%; the remaining 39 were discharged within 21 received CRRT treatment for 6.36 +/- 5.59 days. APACHE II score not able to predict outcome suffering from acute (ARF). On contrary, Systemic Inflammatory Response Syndrome (SIRS) incidence significantly higher in deceased compared recovered patients. In conclusion, it important start dialytic immediately when MOSF show function damage, even if at an initial stage, order improve patients' survival. Moreover a multidisciplinary approach preferable underestimating management metabolic infective complications, nursing care, nutritional support.